{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:50:37Z","timestamp":1765954237499,"version":"3.48.0"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Inborn metabolic diseases (IMDs) represent a diverse and complex group of rare disorders, typically resulting from variants in genes that encode specific enzymes or cofactors, leading to reduced or absent enzymatic activity. These conditions commonly disrupt one or more metabolic pathways, often impacting multiple organ systems from early childhood. Clinicians should consider the possibility of an IMD when an endocrine abnormality is accompanied by other unexplained clinical signs or in presence of combined endocrinopathies. While some IMDs associated with endocrine dysfunction in children and adolescents are well-documented and supported by established treatment guidelines, others lack clear recommendations or are characterized by inconsistent data. This narrative review aims to summarize the main IMDs that present with endocrine abnormalities in pediatric patients, organized according to affected organ systems and underlying pathophysiological mechanisms. Furthermore, we reviewed the latest recommendations, when available, for monitoring endocrine function in children with these disorders and eventually for providing a tailored treatment, where applicable.<\/jats:p>","DOI":"10.3389\/fendo.2025.1717675","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:46:10Z","timestamp":1765953970000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Endocrine system disturbances in children with inherited metabolic diseases: a narrative review"],"prefix":"10.3389","volume":"16","author":[{"given":"Veronica Maria","family":"Tagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Fiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Montanari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Tonduti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilde","family":"Ferrario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Gambino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilenia Pia","family":"Greco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cecchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Calcaterra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianvincenzo","family":"Zuccotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Verduci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-67727-5","volume-title":"Physician\u2019s Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases","author":"Blau","year":"2022"},{"key":"B2","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-49771-5","volume-title":"Inborn Metabolic Diseases","author":"Saudubray","year":"2016"},{"key":"B3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrendo.2016.151","article-title":"Mitochondrial disease and endocrine dysfunction","volume":"13","author":"Chow","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaf002","article-title":"Endocrine dysfunction in primary mitochondrial diseases","volume":"46","author":"Varughese","year":"2025","journal-title":"Endocrine Rev"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24330","article-title":"Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Bacon","year":"2011","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1515\/JPEM.2005.18.6.617\/html","article-title":"Secondary diabetes mellitus: late complication of glycogen storage disease type 1b","volume":"18","author":"Spiegel","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4076\/1757-1627-2-6891","article-title":"Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report","author":"Ismail","year":"2009","journal-title":"cases J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.24911\/SJP.2018.1.3","article-title":"Inborn errors of metabolism associated with hyperglycaemic ketoacidosis and diabetes mellitus: narrative review","volume":"18","author":"Salih","year":"2018","journal-title":"Sudan J Paed"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0858","article-title":"Endocrine dysfunction in patients with fabry disease","volume":"91","author":"Faggiano","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02918-4","article-title":"Endocrine disorders in patients with Fabry disease: insights from a reference centre prospective study","volume":"75","author":"Bothou","year":"2022","journal-title":"Endocrine"},{"key":"B11","first-page":"1","article-title":"Thyroid function in Fabry disease before and after enzyme replacement therapy","volume":"36","author":"Faggiano","year":"2011","journal-title":"Minerva Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(77)80813-5","article-title":"Endocrine studies in cystinosis: Compensated primary hypothyroidism","volume":"91","author":"Lucky","year":"1977","journal-title":"J Pediatrics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e242954","DOI":"10.1136\/bcr-2021-242954","article-title":"Bartter syndrome and hypothyroidism masquerading cystinosis in a 3-year-old girl: rare manifestation of a rare disease","volume":"14","author":"Das","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13023-016-0426-y","article-title":"Cystinosis: a review","volume":"11","author":"Elmonem","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu090","article-title":"Nephropathic cystinosis: an international consensus document","volume":"29","author":"Emma","year":"2014","journal-title":"Nephrol Dialysis Transplant"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/adc.53.12.947","article-title":"Hypothyroidism in children with cystinosis","volume":"53","author":"Burke","year":"1978","journal-title":"Arch Dis Childhood"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.galenos.2025.2024-10-7","article-title":"Endocrine implications of congenital disorders of glycosylation","author":"\u00dcnsal","year":"2025","journal-title":"Jcrpe"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2012.02.001","article-title":"Thyroid function in PMM2-CDG: Diagnostic approach and proposed management","volume":"105","author":"Mohamed","year":"2012","journal-title":"Mol Genet Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.80.12.8530628","article-title":"Thyroid function tests and characterization of thyroxine-binding globulin in the carbohydrate-deficient glycoprotein syndrome type I","volume":"80","author":"Macchia","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jimd.12367","article-title":"Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG","volume":"44","author":"Alsharhan","year":"2021","journal-title":"J Inher Metab Disea"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-014-9778-4","article-title":"Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease","volume":"38","author":"Broomfield","year":"2015","journal-title":"J Inher Metab Disea"},{"key":"B22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2265.1992.tb02289.x","article-title":"Endocrine dysfunction in Kearns-Sayre syndrome","volume":"37","author":"Harvey","year":"1992","journal-title":"Clin Endocrinology"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.4081\/pmc.2013.48","article-title":"Multiple endocrinopathies (growth hormone deficiency, autoimmune hypothyroidism and diabetes mellitus) in Kearns-Sayre syndrome","volume":"35","author":"Berio","year":"2013","journal-title":"Pediatr Med Chir"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1177\/0883073809343313","article-title":"Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease","volume":"25","author":"Hopkins","year":"2010","journal-title":"J Child Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-011-1926-6","article-title":"Renal involvement in mitochondrial cytopathies","volume":"27","author":"Emma","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s004670100637","article-title":"Mitochondrial tubulopathy: the many faces of mitochondrial disorders","volume":"16","author":"Lee","year":"2001","journal-title":"Pediatr Nephrology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000046239","article-title":"Severe hypomagnesemia and hypoparathyroidism in kearns-sayre syndrome","volume":"21","author":"Katsanos","year":"2001","journal-title":"Am J Nephrol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S0140-6736(07)60196-2","article-title":"Wilson\u2019s disease","volume":"369","author":"Ala","year":"2007","journal-title":"Lancet"},{"key":"B29","article-title":"Other organ involvement and clinical aspects of Wilson disease","volume-title":"Handbook of Clinical Neurology","author":"Dzie\u017cyc","year":"2017"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198310133091501","article-title":"Hypoparathyroidism in wilson\u2019s disease","volume":"309","author":"Carpenter","year":"1983","journal-title":"N Engl J Med"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.54516","article-title":"Beyond the norm: unusual coexistence of wilson disease and hypoparathyroidism","author":"Sawant","year":"2024","journal-title":"Cureus"},{"key":"B32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4103\/2230-8210.109689","article-title":"Hypoparathyroidism in a case of Wilson\u2032s disease: Rare association of a rare disorder","volume":"17","author":"Fatima","year":"2013","journal-title":"Indian J Endocr Metab"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(96)70206-8","article-title":"Hypoparathyroidism in mitochondrial trifunctional protein deficiency","volume":"129","author":"Dionisi-Vici","year":"1996","journal-title":"J Pediatrics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.36434","article-title":"Mutations in HADHB, which encodes the \u03b2-subunit of mitochondrial trifunctional protein, cause infantile onset hypoparathyroidism and peripheral polyneuropathy","volume":"164","author":"Naiki","year":"2014","journal-title":"Am J Med Genet Pt A"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-005-0052-5","article-title":"Ogier De Baulny H. Partial hypoparathyroidism associated with mitochondrial trifunctional protein deficiency","volume":"165","author":"Labarthe","year":"2006","journal-title":"Eur J Pediatr"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(97)70111-2","article-title":"Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency caused by the G1528C mutation","volume":"131","author":"Tyni","year":"1997","journal-title":"J Pediatrics"},{"key":"B37","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1023\/a:1005556207210","article-title":"Recognition and management of fatty acid oxidation defects: A series of 107 patients","volume":"22","author":"Saudubray","year":"1999","journal-title":"J Inher Metab Disea"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.8.1485","article-title":"Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy","volume":"120","author":"Moser","year":"1997","journal-title":"Brain"},{"key":"B39","article-title":"Adrenal Insufficiency Due to X-Linked Adrenoleukodystrophy","volume-title":"Endotext [Internet]","author":"Kanakis","year":"2000"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2605.1997.00066.x","article-title":"Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study","volume":"20","author":"Assies","year":"1997","journal-title":"Int J Andrology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401330","article-title":"X-linked adrenoleukodystrophy: are signs of hypogonadism always due to testicular failure","volume":"13","author":"Karapanou","year":"2014","journal-title":"Hormones"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0490","article-title":"Reproductive function in men affected by X-linked adrenoleukodystrophy\/adrenomyeloneuropathy","volume":"166","author":"Stradomska","year":"2012","journal-title":"Eur J Endocrinology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.9.2474","article-title":"Rapid decline of fertility in a case of adrenoleukodystrophy","volume":"13","author":"Aversa","year":"1998","journal-title":"Hum Reproduction"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-010-9221-4","article-title":"Ovarian function in girls and women with GALT-deficiency galactosemia","volume":"34","author":"Fridovich-Keil","year":"2011","journal-title":"J Inher Metab Disea"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-49771-5_6","article-title":"Disorders of Galactose Metabolism","volume-title":"Inborn Metabolic Diseases","author":"Berry","year":"2016"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.05.088","article-title":"Ovarian function in Duarte galactosemia","volume":"96","author":"Badik","year":"2011","journal-title":"Fertility Sterility"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-016-9990-5","article-title":"International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up","volume":"40","author":"Welling","year":"2017","journal-title":"J Inher Metab Disea"},{"key":"B48","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1750-1172-8-107","article-title":"Fertility preservation in female classic galactosemia patients","volume":"8","author":"Van Erven","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2006.07.005","article-title":"The endocrine system in treated patients with classical galactosemia","volume":"89","author":"Rubio-Gozalbo","year":"2006","journal-title":"Mol Genet Metab"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/s0890-6238(00)00096-4","article-title":"Galactose metabolism and ovarian toxicity","volume":"14","author":"Liu","year":"2000","journal-title":"Reprod Toxicology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/BF00731085","article-title":"Glycosylation of pituitary hormones: a necessary and multistep control of biopotency","volume":"9","author":"Ronin","year":"1992","journal-title":"Glycoconj J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00098","article-title":"Roles for golgi glycans in oogenesis and spermatogenesis","volume":"7","author":"Akintayo","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.10.030","article-title":"Fertility management in cystinosis: A clinical perspective","volume":"9","author":"Langman","year":"2024","journal-title":"Kidney Int Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.3390\/cells10123539","article-title":"Fertility in cystinosis","volume":"10","author":"Reda","year":"2021","journal-title":"Cells"},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-49771-5_42","article-title":"Cystinosis","volume-title":"Inborn Metabolic Diseases","author":"Niaudet","year":"2016"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00620.x","article-title":"Hormonal profile and fertility in patients with Anderson-Fabry disease: Hormones and Anderson-Fabry Disease","volume":"59","author":"Hauser","year":"2005","journal-title":"Int J Clin Practice"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711410203","article-title":"Testicular and epididymal involvement in Fabry\u2019s disease","volume":"141","author":"Nistal","year":"1983","journal-title":"J Pathology"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.1985.tb00826.x","article-title":"Stagnation of blood in the microcirculatory vessels in the testes of men with varicocele","volume":"6","author":"Chakraborty","year":"1985","journal-title":"J Andrology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2022.07.010","article-title":"An expert consensus on practical clinical recommendations and guidance for patients with classic Fabry disease","volume":"137","author":"Germain","year":"2022","journal-title":"Mol Genet Metab"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-012-9490-1","article-title":"Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study","volume":"36","author":"Sechi","year":"2013","journal-title":"J Inher Metab Disea"},{"key":"B62","first-page":"1993","article-title":"Glycogen Storage Disease Type I","volume-title":"GeneReviews","author":"Bali","year":"2006"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02686.x","article-title":"The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism","volume":"42","author":"Lee","year":"1995","journal-title":"Clin Endocrinology"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000435451.86108.82","article-title":"Menorrhagia in patients with type I glycogen storage disease","volume":"122","author":"Austin","year":"2013","journal-title":"Obstetrics Gynecology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200204000-00008","article-title":"Desmopressin in the treatment of menorrhagia in women with no common coagulation factor deficiency but with prolonged bleeding time","volume":"13","author":"Edlund","year":"2002","journal-title":"Blood Coagulation Fibrinolysis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V68.1.180.180","article-title":"DDAVP infusion in five patients with type Ia glycogen storage disease and associated correction of prolonged bleeding times","volume":"68","author":"Marti","year":"1986","journal-title":"Blood"},{"key":"B67","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1007\/s00431-002-1013-x","article-title":"Contraception and pregnancy in women affected by glycogen storage diseases","volume":"161","author":"Mairovitz","year":"2002","journal-title":"Eur J Pediatrics"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei358","article-title":"A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants","volume":"21","author":"Bahamondes","year":"2006","journal-title":"Hum Reproduction"},{"key":"B69","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00439-023-02563-z","article-title":"Deficiency of the mitochondrial ribosomal subunit, MRPL50, causes autosomal recessive syndromic premature ovarian insufficiency","volume":"142","author":"Bakhshalizadeh","year":"2023","journal-title":"Hum Genet"},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-49771-5_14","article-title":"Disorders of Oxidative Phosphorylation","volume-title":"Inborn Metabolic Diseases","author":"Rahman","year":"2016"},{"key":"B71","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41420-025-02501-0","article-title":"AARS2-catalyzed lactylation induces follicle development and premature ovarian insufficiency","volume":"11","author":"Zhang","year":"2025","journal-title":"Cell Death Discov"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2016.90","article-title":"Adrenoleukodystrophy \u2013 neuroendocrine pathogenesis and redefinition of natural history","volume":"12","author":"Kemp","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-01307","article-title":"The natural history of adrenal insufficiency in X-linked adrenoleukodystrophy: an international collaboration","volume":"104","author":"Huffnagel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad286","article-title":"Early detection of adrenal insufficiency: the impact of newborn screening for adrenoleukodystrophy","volume":"108","author":"Ramirez Alcantara","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.10.067","article-title":"Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening","volume":"146","author":"Dubey","year":"2005","journal-title":"J Pediatrics"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00920","article-title":"Adrenoleukodystrophy: guidance for adrenal surveillance in males identified by newborn screen","volume":"103","author":"Regelmann","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.2288","article-title":"Endocrine dysfunctions in patients with inherited metabolic diseases","volume":"8","author":"Erd\u00f6l","year":"2016","journal-title":"Jcrpe"},{"key":"B78","article-title":"Adrenoleukodystrophy","volume-title":"StatPearls","author":"Alsaleem","year":"2024"},{"key":"B79","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ymgme.2015.02.002","article-title":"Newborn screening for X-linked adrenoleukodystrophy in New York State: Diagnostic protocol, surveillance protocol and treatment guidelines","volume":"114","author":"Vogel","year":"2015","journal-title":"Mol Genet Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19990219)82:5<382::AID-AJMG5>3.0.CO;2-9","article-title":"Adrenal insufficiency in Smith-Lemli-Opitz syndrome","volume":"82","author":"Andersson","year":"1999","journal-title":"Am J Med Genet"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1159\/000070226","article-title":"Adrenal insufficiency and abnormal genitalia in a 46XX female with smith-lemli-opitz syndrome","volume":"59","author":"Chemaitilly","year":"2003","journal-title":"Horm Res Paediatr"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.1545","article-title":"Adrenal insufficiency and hypertension in a newborn infant with Smith-Lemli-Opitz syndrome","volume":"103","author":"Nowaczyk","year":"2001","journal-title":"Am J Med Genet"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.34271","article-title":"Adrenal function in Smith\u2013Lemli\u2013Opitz syndrome","volume":"155","author":"Bianconi","year":"2011","journal-title":"Am J Med Genet Pt A"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1097\/00019605-199707000-00011","article-title":"Smith-Lemli-Opitz syndrome: further delineation of the phenotype","volume":"6","author":"Worthington","year":"1997","journal-title":"Clin Dysmorphology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(02)00155-3","article-title":"Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patients with 7-dehydrosterol-\u03947-reductase deficiency (Smith\u2013Lemli\u2013Opitz syndrome)","volume":"82","author":"Shackleton","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B86","first-page":"1993","article-title":"Smith-Lemli-Oitz Syndrome","volume-title":"Gene Reviews","author":"Irons","year":"1998"},{"key":"B87","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-49771-5_32","article-title":"Disorders of Isoprenoid\/Cholesterol Synthesis","volume-title":"Inborn Metabolic Diseases","author":"Waterham","year":"2016"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2013.12.009","article-title":"Adrenal insufficiency in a child with MELAS syndrome","volume":"36","author":"Afroze","year":"2014","journal-title":"Brain Dev"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/ijms24021126","article-title":"Adrenal dysfunction in mitochondrial diseases","volume":"24","author":"Corkery-Hayward","year":"2023","journal-title":"IJMS"},{"key":"B90","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000023243","article-title":"Multiple endocrine involvement in two pediatric patients with kearns-sayre syndrome","volume":"50","author":"Artuch","year":"1998","journal-title":"Horm Res Paediatr"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050902","article-title":"Mitochondrial DNA deletion with Kearns Sayre syndrome in a child with Addison disease","volume":"157","author":"Boles","year":"1998","journal-title":"Eur J Pediatrics"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-012-1798-1","article-title":"A rare case report of simultaneous presentation of myopathy, Addison\u2019s disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns\u2013Sayre syndrome","volume":"172","author":"Tzoufi","year":"2013","journal-title":"Eur J Pediatr"},{"key":"B93","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/8904_2011_33","article-title":"Large Mitochondrial DNA Deletion in an Infant with Addison Disease","volume-title":"JIMD Reports - Case and Research Reports","author":"Duran","year":"2011"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2021.06.003","article-title":"Should patients with Phosphomannomutase 2-CDG (PMM2-CDG) be screened for adrenal insufficiency","volume":"133","author":"\u010cechov\u00e1","year":"2021","journal-title":"Mol Genet Metab"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2017.10.010","article-title":"Group 1. Epidemiology of primary and secondary adrenal insufficiency: Prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality","volume":"78","author":"Chabre","year":"2017","journal-title":"Annales d\u2019Endocrinologie"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1023\/a:1005660826652","article-title":"Isolated and contiguous glycerol kinase gene disorders: A review","volume":"23","author":"Sjarif","year":"2000","journal-title":"J Inher Metab Disea"},{"key":"B97","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-662-49771-5_7","article-title":"Disorders of Glycolysis and the Pentose Phosphate Pathway","volume-title":"Inborn Metabolic Diseases","author":"Wamelink","year":"2016"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.2539","article-title":"Complex glycerol kinase deficiency and adrenocortical insufficiency in two neonates","volume":"8","author":"Korkut","year":"2016","journal-title":"Jcrpe"},{"key":"B99","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13023-014-0133-5","article-title":"High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders","volume":"9","author":"Berendse","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/9826930","article-title":"Diabetes in HFE hemochromatosis","volume":"2017","author":"Barton","year":"2017","journal-title":"J Diabetes Res"},{"key":"B101","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1750-1172-7-11","article-title":"Endocrine manifestations related to inherited metabolic diseases in adults","volume":"7","author":"Vantyghem","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21938","article-title":"Aceruloplasminemia: A novel mutation in a family with marked phenotypic variability","volume":"23","author":"Fasano","year":"2008","journal-title":"Movement Disord"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2011.00784.x","article-title":"Methylmalonic acidemia mimicking diabetic ketoacidosis in an infant","volume":"13","author":"Guven","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2015-0228\/html","article-title":"Isolated methylmalonic acidemia with unusual presentation mimicking diabetic ketoacidosis","volume":"29","author":"Dejkhamron","year":"2016","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B105","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","article-title":"Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia","volume":"9","author":"Baumgartner","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2010.06.016","article-title":"Propionic acidemia mimicking diabetic ketoacidosis","volume":"33","author":"Dweikat","year":"2011","journal-title":"Brain Dev"},{"key":"B107","article-title":"Propionic acidemia presenting as diabetic ketoacidosis","volume":"48","author":"Joshi","year":"2011","journal-title":"Indian Pediatr"},{"key":"B108","article-title":"Isovaleric acidemia: report of one case","volume":"31","author":"Hou","year":"1990","journal-title":"Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1515\/jpem.2010.082\/html","article-title":"Chronic intermittent form of isovaleric acidemia mimicking diabetic ketoacidosis","volume":"23","author":"Erdem","year":"2010","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B110","doi-asserted-by":"publisher","first-page":"59","DOI":"10.4274\/Jcrpe.1181","article-title":"Isovaleric acidemia presenting as diabetic ketoacidosis: A case report","volume":"6","author":"K\u0131l\u0131\u00e7","year":"2014","journal-title":"Jcrpe"},{"key":"B111","article-title":"Biotin responsive multiple carboxylase deficiency presenting as diabetic ketoacidosis","volume":"27","author":"Hou","year":"2004","journal-title":"Chang Gung Med J"},{"key":"B112","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13023-021-01685-9","article-title":"Pancreatic involvement in patients with inborn errors of metabolism","volume":"16","author":"Hwang","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-1141-9","article-title":"Insulin-resistant hyperglycaemia complicating neonatal onset of methylmalonic and propionic acidaemias","volume":"32","author":"Filippi","year":"2009","journal-title":"J Inher Metab Disea"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2011.07.002","article-title":"Methylmalonic acidemia and hyperglycemia: An unusual association","volume":"34","author":"Imen","year":"2012","journal-title":"Brain Dev"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.2007.S103","article-title":"Mitochondrial diabetes","volume":"53","author":"Maassen","year":"2004","journal-title":"Diabetes"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-007-0779-9","article-title":"Prevalence and progression of diabetes in mitochondrial disease","volume":"50","author":"Whittaker","year":"2007","journal-title":"Diabetologia"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-303528","article-title":"The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation\u2013implications for diagnosis and management","volume":"84","author":"Nesbitt","year":"2013","journal-title":"J Neurology Neurosurg Psychiatry"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/pedi.12223","article-title":"The spectrum of clinical presentation, diagnosis, and management of mitochondrial forms of diabetes: Diabetes in mitochondrial diseases","volume":"16","author":"Karaa","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.06.004","article-title":"Endocrine disorders in mitochondrial disease","volume":"379","author":"Schaefer","year":"2013","journal-title":"Mol Cell Endocrinology"},{"key":"B120","doi-asserted-by":"publisher","first-page":"6286","DOI":"10.3390\/ijms21176286","article-title":"Fanconi\u2013bickel syndrome: A review of the mechanisms that lead to dysglycaemia","volume":"21","author":"Sharari","year":"2020","journal-title":"IJMS"},{"key":"B121","doi-asserted-by":"publisher","first-page":"eabn4214","DOI":"10.1126\/scitranslmed.abn4214","article-title":"The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI","volume":"15","author":"Trepiccione","year":"2023","journal-title":"Sci Transl Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ando.2009.09.001","article-title":"Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia","volume":"70","author":"Bouyahia","year":"2009","journal-title":"Annales d\u2019Endocrinologie"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02305","article-title":"Thiamine transporter mutation: an example of monogenic diabetes mellitus","volume":"155","author":"Alzahrani","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"B124","article-title":"Thiamine-Responsive Megaloblastic Anemia Syndrome","volume-title":"GeneReviews","author":"Sako","year":"1993"},{"key":"B125","article-title":"Five years followup of diabetes mellitus in two siblings with thiamine responsive megaloblastic anemia","volume":"38","author":"Bappal","year":"2001","journal-title":"Indian Pediatr"},{"key":"B126","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2337\/diacare.21.1.38","article-title":"Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome","volume":"21","author":"Valerio","year":"1998","journal-title":"Diabetes Care"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-4-200708210-00006","article-title":"Nephropathic cystinosis in adults: natural history and effects of oral cysteamine therapy","volume":"147","author":"Gahl","year":"2007","journal-title":"Ann Intern Med"},{"key":"B128","doi-asserted-by":"crossref","DOI":"10.1007\/s004310050926","article-title":"Slowly deteriorating insulin secretion and C-peptide production characterizes diabetes mellitus in infantile cystinosis","volume":"157","author":"Filler","year":"1998","journal-title":"Eur J Pediatrics"},{"key":"B129","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrendo.2010.210","article-title":"Alstr\u00f6m syndrome: insights into the pathogenesis of metabolic disorders","volume":"7","author":"Girard","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/archinte.165.6.675","article-title":"New alstr\u00f6m syndrome phenotypes based on the evaluation of 182 cases","volume":"165","author":"Marshall","year":"2005","journal-title":"Arch Intern Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2010.00698.x","article-title":"Presentation and course of diabetes in children and adolescents with Alstrom syndrome","volume":"12","author":"Mokashi","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"B132","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/jmd2.12085","article-title":"Hypoglycemia in CDG patients due to PMM2 mutations: Follow up on hyperinsulinemic patients","volume":"51","author":"Moravej","year":"2020","journal-title":"JIMD Rep"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-020-03804-3","article-title":"Central precocious puberty may be a manifestation of endocrine dysfunction in pediatric patients with mitochondrial disease","volume":"180","author":"Chae","year":"2021","journal-title":"Eur J Pediatr"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1177\/088307380001501108","article-title":"Endocrine disorders in two sisters affected by MELAS syndrome","volume":"15","author":"Balestri","year":"2000","journal-title":"J Child Neurol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-36742","article-title":"Hypothalamic growth hormone deficiency and supplementary GH therapy in two patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes","volume":"33","author":"Matsuzaki","year":"2002","journal-title":"Neuropediatrics"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2014-0315\/html","article-title":"Growth hormone deficiency in a patient with mitochondrial disease","volume":"28","author":"Rocha","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2007.09.007","article-title":"Variable outcome of growth hormone administration in respiratory chain deficiency","volume":"93","author":"Romano","year":"2008","journal-title":"Mol Genet Metab"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1111\/j.1651-2227.1982.tb09504.x","article-title":"GROWTH HORMONE DEFICIENCY IN MITOCHONDRIAL CYTOPATHY","volume":"71","author":"Burns","year":"1982","journal-title":"Acta Paediatrica"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0451-7","article-title":"Endocrine dysfunction in hereditary hemochromatosis","volume":"39","author":"Pelusi","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B140","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00005072-197809000-00068","article-title":"Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study","volume":"93","author":"Bergeron","year":"1978","journal-title":"Am J Pathol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00000441-198305000-00002","article-title":"The endocrine manifestations of hemochromatosis","volume":"285","author":"McNeil","year":"1983","journal-title":"Am J Med Sci"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-43-4-866","article-title":"A study of pituitary function in patients with idiopathic hemochromatosis","volume":"43","author":"Walsh","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(68)90182-4","article-title":"Pituitary function in haemochromatosis","volume":"45","author":"Stocks","year":"1968","journal-title":"Am J Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.0980178","article-title":"Pituitary function in idiopathic haemochromatosis: hormonal study in 36 male patients","volume":"98","author":"Charbonnel","year":"1981","journal-title":"Acta Endocrinologica"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840050216","article-title":"Androgen and estrogen response to adrenal and gonadal stimulation in idiopathic hemochromatosis: evidence for decreased estrogen formation","volume":"5","author":"Kley","year":"1985","journal-title":"Hepatology"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1280351","article-title":"Non-responsiveness of serum gonadotropins and testosterone to pulsatile GnRH in hemochromatosis suggesting a pituitary defect","volume":"128","author":"Duranteau","year":"1993","journal-title":"Acta Endocrinologica"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0980","article-title":"Hypogonadism in hereditary hemochromatosis","volume":"90","author":"McDermott","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-5-629","article-title":"Hypogonadism in hemochromatosis: reversal with iron depletion","volume":"101","author":"Kelly","year":"1984","journal-title":"Ann Intern Med"},{"key":"B149","article-title":"Successful pregnancy following gonadotropin therapy in a young female with juvenile idiopathic hemochromatosis and secondary hypogonadotropic hypogonadism","volume":"80","author":"Farina","year":"1995","journal-title":"Haematologica"},{"key":"B150","article-title":"Homozygous G320V mutation in the HJV gene causing juvenile hereditary haemochromatosis type A","volume":"19","author":"Militaru","year":"2010","journal-title":"A Case Rep J Gastrointestin Liver Dis"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb02143.x","article-title":"Reversibility of hypogonadotrophic hypogonadism associated with genetic haemochromatosis","volume":"38","author":"Cundy","year":"1993","journal-title":"Clin Endocrinology"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200108000-00021","article-title":"Successful treatment of erectile dysfunction and infertility by venesection in a patient with primary haemochromatosis","volume":"13","author":"Hamer","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1159\/000117150","article-title":"Gonadal dysfunction in mitochondrial encephalomyopathies","volume":"35","author":"Chen","year":"1995","journal-title":"Eur Neurol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2007.01720.x","article-title":"Cognitive dysfunction and hypogonadotrophic hypogonadism in a Brazilian patient with mitochondrial neurogastrointestinal encephalomyopathy and a novel ECGF1 mutation","volume":"14","author":"Carod-Artal","year":"2007","journal-title":"Euro J Neurology"},{"key":"B155","first-page":"13","article-title":"Dysfunction of the hypothalamic-pituitary system in mitochondrial encephalomyopathies","volume":"29","author":"Ohkoshi","year":"1998","journal-title":"J Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1717675\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:46:24Z","timestamp":1765953984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1717675\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":155,"alternative-id":["10.3389\/fendo.2025.1717675"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1717675","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"article-number":"1717675"}}